Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years
NCT03131648 (ECZTRA 1); study start date: 30 May, 2017; primary completion date: 7 August, 2018; study completion date: 10 October, 2019. NCT03160885 (ECZTRA 2); study start date: 12 June, 2017; primary completion date: 4 September, 2019; study completion date: 14 August, 2019. NCT03587805 (ECZTEND); study start date: 18 March, 2018; data cut-off date: 30 April, 2022; primary completion date: 3 July, 2024; study completion date: 3 July, 2024.
Authors
- Simone Ribero (ORCID: https://orcid.org/0000-0002-0098-1406)
- Christian Bjerregård Øland (ORCID: https://orcid.org/0000-0001-8929-1761)
- Jacob Pontoppidan Thyssen (ORCID: https://orcid.org/0000-0003-3770-1743)
- Hidehisa Saeki (ORCID: https://orcid.org/0000-0002-1095-0355)
- Raj Chovatiya (ORCID: https://orcid.org/0000-0001-6510-399X)
- Le Gjerum (ORCID: https://orcid.org/0000-0002-5849-1397)
- Chang Ook Park (ORCID: https://orcid.org/0000-0003-3856-1201)
- Hwanhee Hong (ORCID: https://orcid.org/0000-0002-3736-6327)
- Douglas Maslin (ORCID: https://orcid.org/0000-0002-5440-4436)
- Andreas Wollenberg (ORCID: https://orcid.org/0000-0003-0177-8722)
- Andrew Blauvelt (ORCID: https://orcid.org/0000-0002-2633-985X)
- Julien Sénéschal (ORCID: https://orcid.org/0000-0003-1139-0908)
- Juan Francisco Silvestre
Institutions
- University of Copenhagen (DK)
- Centre National de la Recherche Scientifique (FR)
- University of British Columbia (CA)
- Université de Bordeaux (FR)
- Rosalind Franklin University of Medicine and Science (US)
- Yonsei University (KR)
- Severance Hospital (KR)
- Bispebjerg Hospital (DK)
- University Hospital Augsburg (DE)
- Zealand Pharma (Denmark) (DK)
- Maryland Department of Natural Resources (US)
- Hôpital Saint-André (FR)
- Immunology from Concept and Experiments to Translation (FR)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
- Center for Clinical Research (United States) (US)
- Addenbrooke's Hospital (GB)
- Leo Pharma (Denmark) (DK)
- Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) (ES)
- University of Turin (IT)
- Nippon Medical School (JP)
- Ludwig-Maximilians-Universität München (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- American Journal of Clinical Dermatology
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1007/s40257-025-00931-1
- Citations
- 15
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 30.07
Funders
- LEO Pharma